Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Avai BioAVAI -18.38%24 3-Year EPS without NRI Growth Rate is -26.00% as of Dec. 2025. GuruFocus rates AVAI with a GF Score™ of 24/100. The stock has 3 warning signs investors should review. Among 2,074 Software companies, Avai Bio ranks worse than 86.02% on this metric.
During the past 3 years, the average EPS without NRI Growth Rate was -26.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 8 years, the highest 3-Year average EPS without NRI Growth Rate of Avai Bio was -18.60% per year. The lowest was -71.00% per year. And the median was -26.00% per year.
Avai Bio (OTCPK:AVAI) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Avai Bio 3-Year EPS without NRI Growth Rate Related Terms
AVAI vs IPM, CRMZ, AWRE: 3-Year EPS without NRI Growth Rate Comparison
For the Software - Application subindustry, Avai Bio's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avai Bio 3-Year EPS without NRI Growth Rate vs Software Industry
For the Software industry and Technology sector, Avai Bio's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Avai Bio's 3-Year EPS without NRI Growth Rate falls into.
Avai Bio 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of -26.00% mean?
Avai Bio (AVAI) has a 3-Year EPS without NRI Growth Rate of -26.00% as of Dec. 2025. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Avai Bio and its competitors. According to the industry distribution chart, Avai Bio ranks #1784 out of 2074 companies in the Software industry, placing it in the top 86%.
Is Avai Bio's 3-Year EPS without NRI Growth Rate too high?
Avai Bio's current 3-Year EPS without NRI Growth Rate is -26.00%. Based on the distribution chart, Avai Bio ranks #1784 out of 2074 companies in the Software industry, which is in the bottom quartile relative to peers. Overall, Avai Bio has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Avai Bio's 3-Year EPS without NRI Growth Rate compare to IPM and CRMZ?
According to the Software industry distribution chart, Avai Bio ranks #1784 out of 2074 companies for 3-Year EPS without NRI Growth Rate. This places Avai Bio in the lower half of its industry. The industry median 3-Year EPS without NRI Growth Rate is 12.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Software company?
The median 3-Year EPS without NRI Growth Rate among Software companies is 12.50, based on 2,074 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Avai Bio and its competitors. For the Software industry, the median 3-Year EPS without NRI Growth Rate is 12.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avai Bio's current 3-Year EPS without NRI Growth Rate is -26.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avai Bio stock overvalued right now?
Avai Bio (AVAI) has a current 3-Year EPS without NRI Growth Rate of -26.00%. The current 3-Year EPS without NRI Growth Rate is -26.00%. Avai Bio's overall GF Score™ is 24/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Avai Bio (AVAI), the current 3-Year EPS without NRI Growth Rate is -26.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Avai Bio Inc is a biotechnology company focused on identifying genetically modified cell lines, and through joint venture and licensing agreements, developing cell-based therapies. The company has two development programs in its cellular therapies pipeline, a diabetes development program to advance a treatment for type 1 and type 2 insulin-dependent diabetes, and an ?-Klotho protein development program to advance therapies for age-related diseases and anti-aging treatments.
24GF Score
Get the complete analysis for AVAI
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AVAI has been successfully added to your 
